DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Technologies that can change the way we measure and perceive vaccination-induced immune protection will eliminate the uncertainty and retrospective evaluation ...
Tag: DARPA
DARPA Pursues Advanced Threat-Detection for Crop Defense
DARPA’s Foundational Security for Food Systems (FS2) program will explore a pathway-based approach to provide advanced threat detection and warning ...
Targeting Poxviruses with Messenger RNA Technology
Scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) working with industry partners are among the first ...
Send in the Blow Flies: Using Insects to Sample Areas for Chemical Warfare Agents
Researchers at the School of Science at IUPUI have found that blow flies can be used as chemical sensors, with ...
On Demand Pharmaceuticals Opens State-of-the-Art Manufacturing Facility in Maryland
Agile biomanufacturing technology incubated by DARPA reaches commercial facility milestone On Demand Pharmaceuticals, Inc. (ODP) announced on Feb. 15 the ...
DARPA Program Aims to Develop Fundamentals of Biomanufacturing in Space
The B-SURE (Biomanufacturing: Survival, Utility, and Reliability beyond Earth) program will leverage biological processes in resource limited environments. Imagine you ...
Protective Biosystems: Parasites to Fight Chemical and Biological Weapons
Parasites could become part of the armour of military personnel and first responders to help them counter chemical and biological ...
Leidos Awarded DARPA Contract for Personalized Protective Biosystem Against Chemical and Biological Threats
Personalized Protective Biosystem (PPB) program aims to develop technology that reduces the need for burdensome protective equipment while increasing individual ...
Project Arcadia: Harnessing Bacteria to Build Resilient Biofilm Coatings for DoD Equipment
DARPA’s new project will develop “probiotics for materials” to build protective and beneficial coatings Bacteria are the most abundant and ...
mRNA Treatment Shows Promise for Stopping Flu and COVID-19 Viruses
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory ...
DARPA Grant to Texas Tech Funds Development of Indoor Airborne Virus Sensor
Carbon monoxide is a colorless, odorless gas that can cause headaches, dizziness and even death in certain circumstances. Since this ...
DARPA Awards Nucleic Acids On-Demand (NOW) Contract to GE Research and Collaborators
The Defense Advanced Research Projects Agency (DARPA) has awarded project funding worth up to $41 million to GE Research and a ...
Securing Synthetic Biology Data At Risk During the COVID-19 Pandemic
A partnership between Sandia National Laboratories and the Boston firm BioBright LLC to improve the security of synthetic biology equipment ...
DARPA Seeks Innovations in Rapid DNA Molecule Manufacturing
DARPA is interested in understanding the feasibility of rapid, flexible manufacturing of DNA molecules for synthetic biology and therapeutic applications. ...
AbCellera and Eli Lilly to Co-Develop COVID-19 Therapeutic Antibodies
AbCellera Biologics Inc. and Eli Lilly today announced they would co-develop antibody products for the treatment of COVID-19, the disease ...
Profusa and Partners Announce DARPA-Backed Study to Measure Early Signs of Influenza
Profusa, a digital health company that is pioneering the next generation of personalized medicine, today announced the initiation of a ...
DARPA P3 Researchers Race to Create Treatment for the Novel Coronavirus
Researchers working under DARPA's Pandemic Preparedness Platform (P3) are racing to apply their experimental techniques to a true pandemic playing out ...
Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans
A new University of California, Berkeley, study finds that bats' fierce immune response to viruses could drive viruses to replicate ...
Antibody Mixture May Help Block Ebola Virus Infection
A research team led by scientists at Vanderbilt University Medical Center has developed an antibody mixture that in animals is ...
AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program
AbCellera confirms that it is mobilizing its pandemic response platform against the ongoing outbreak of a novel coronavirus (2019-nCoV) originating ...
